Glenmark Pharmaceuticals Limited has informed the Exchange that Revised Record date for the purpose of Dividend is 03-Oct-2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has revised the record date for the purpose of interim dividend to Friday, October 3, 2025. The Board of Directors is scheduled to meet on September 26, 2025 to consider and approve the payment of interim dividend, if any, on equity shares for the financial year 2025-26. Shareholders whose names appear in the company's records as of the revised record date will be eligible to receive the dividend, if declared. The original record date communicated earlier stands superseded by this revised date.
Investors need to ensure they hold Glenmark shares in their demat accounts by October 3, 2025 to be eligible for the interim dividend, if declared. The actual dividend amount and its impact on the stock will be known after the Board meeting on September 26, 2025.